Iceland· IS-IS/1/19/084/01

Slinda

A drospirenone product containing drospirenonum inn, registered in Iceland by Exeltis Healthcare S.L.*. The same ATC class is registered in 13 of our 19 countries.

ATC G03AC10

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedSlindaATCG03AC10REGISTER NO.IS-IS/1/19/084/01PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Drospirenone is registered in 13 of 19 countries.

Countries holding a registration under ATC G03AC10 (drospirenone), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 8 of them publish a price we can compare per daily dose

Drospirenone · ATC G03AC10

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Drospirenonum INN
Manufacturer
Exeltis Healthcare S.L.*
Country
Iceland (IS)
ATC code
G03AC10
ATC class
Drospirenone
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

172 interactions on record for drospirenone.

Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Drospirenone · interactions on record

172 records

  • 27 severe
  • 143 moderate
  • 2 minor

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • GriseofulvinD01AA08severe
  • GriseofulvinD01BA01severe
  • KetoconazoleH02CA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca860733-6ce4-4bfb-894f-370c62d32474
GET /v1/drugs/ca860733-6ce4-4bfb-894f-370c62d32474?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmuhúðuð tafla",
  "source": "lyfjastofnun",
  "atc_raw": "G03AC10",
  "marketed": false,
  "strength": "4 mg",
  "ma_number": "IS/1/19/084/01",
  "substance": "Drospirenonum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "43845"
}

See everything about drospirenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.